PDS Biotechnology Corp Increase (Decrease) in Accounts Payable
PDS Biotechnology Corp (PDSB) reported Increase (Decrease) in Accounts Payable of $2.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- PDS Biotechnology Corp increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.74M, a 67.48% increase year-over-year.
- PDS Biotechnology Corp increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $75.90K, a 93.54% decline year-over-year.
- PDS Biotechnology Corp increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.61M, a 518.41% decline year-over-year.
- PDS Biotechnology Corp increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $683.49K.
- PDS Biotechnology Corp increase (decrease) in accounts payable for fiscal 2025 was $1.89M.
- PDS Biotechnology Corp increase (decrease) in accounts payable for fiscal 2024 was -$5.30M, a 191.92% decline from fiscal 2023.
- PDS Biotechnology Corp increase (decrease) in accounts payable for fiscal 2023 was $5.76M.
- PDS Biotechnology Corp increase (decrease) in accounts payable for fiscal 2022 was -$90.12K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.82M 10-Q · filed 2026-08-13 | $1.21M derived: sum of 3 quarters · filed 2026-08-13 | $1.90M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $75.90K 10-Q · filed 2026-05-14 | -$1.53M derived: sum of 2 quarters · filed 2026-05-14 | -$847.08K derived: sum of 3 quarters · filed 2026-05-14 | $791.06K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$922.99K derived: sum of 2 quarters · filed 2026-03-30 | $715.16K derived: sum of 3 quarters · filed 2026-08-13 | $1.89M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $683.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.32M derived: sum of 2 quarters · filed 2026-08-13 | $3.50M 10-Q · filed 2025-11-13 | $3.88M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.81M 10-Q · filed 2026-08-13 | $3.20M derived: sum of 3 quarters · filed 2026-08-13 | $1.24M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.17M 10-Q · filed 2026-05-14 | $1.56M derived: sum of 2 quarters · filed 2026-05-14 | -$393.20K derived: sum of 3 quarters · filed 2026-05-14 | -$3.14M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $383.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.57M derived: sum of 2 quarters · filed 2026-03-30 | -$4.32M derived: sum of 3 quarters · filed 2026-03-30 | -$5.30M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$4.70M derived: sum of 2 quarters · filed 2025-11-13 | -$5.68M 10-Q · filed 2025-11-13 | -$4.07M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.73M 10-Q · filed 2025-08-13 | -$2.11M derived: sum of 3 quarters · filed 2025-08-13 | -$1.16M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$981.99K 10-Q · filed 2025-05-14 | $634.27K derived: sum of 2 quarters · filed 2025-05-14 | $1.59M derived: sum of 3 quarters · filed 2025-05-14 | $3.93M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.57M derived: sum of 2 quarters · filed 2025-03-27 | $4.91M derived: sum of 3 quarters · filed 2025-03-27 | $5.76M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $951.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $3.29M derived: sum of 2 quarters · filed 2024-11-14 | $4.15M 10-Q · filed 2024-11-14 | $3.33M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $3.20M 10-Q · filed 2024-08-13 | $2.38M derived: sum of 3 quarters · filed 2024-08-13 | $2.54M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $852.77K 10-Q · filed 2024-05-15 | $34.67K derived: sum of 2 quarters · filed 2024-05-15 | $194.07K derived: sum of 3 quarters · filed 2024-05-15 | -$673.65K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$818.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$658.70K derived: sum of 2 quarters · filed 2024-03-28 | -$1.53M derived: sum of 3 quarters · filed 2024-03-28 | -$90.12K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $159.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$708.32K derived: sum of 2 quarters · filed 2023-11-14 | $727.99K 10-Q · filed 2023-11-14 | $591.80K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$867.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $568.59K 10-Q · filed 2023-08-14 | $432.41K derived: sum of 3 quarters · filed 2023-08-14 | -$497.37K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $1.44M 10-Q · filed 2023-05-15 | $1.30M derived: sum of 2 quarters · filed 2023-05-15 | $370.35K derived: sum of 3 quarters · filed 2023-05-15 | $1.80M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$136.18K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$1.07M derived: sum of 2 quarters · filed 2023-03-28 | $358.81K derived: sum of 3 quarters · filed 2023-03-28 | -$105.82K 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | -$929.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $494.99K derived: sum of 2 quarters · filed 2022-11-14 | $30.36K 10-Q · filed 2022-11-14 | -$114.01K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $960.14K 10-Q · filed 2022-08-08 | $815.77K derived: sum of 3 quarters · filed 2022-08-08 | $1.28M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | -$464.63K 10-Q · filed 2022-05-11 | -$608.99K derived: sum of 2 quarters · filed 2022-05-11 | -$141.93K derived: sum of 3 quarters · filed 2022-05-11 | -$1.61M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | -$144.37K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $322.70K derived: sum of 2 quarters · filed 2022-03-31 | -$1.14M derived: sum of 3 quarters · filed 2022-03-31 | $217.50K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $467.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$997.11K derived: sum of 2 quarters · filed 2021-11-10 | $361.87K 10-Q · filed 2021-11-10 | -$94.28K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$105.19K 10-Q · filed 2021-08-12 | -$561.34K derived: sum of 3 quarters · filed 2021-08-12 | -$925.69K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.36M 10-Q · filed 2021-05-13 | $902.83K derived: sum of 2 quarters · filed 2021-05-13 | $538.49K derived: sum of 3 quarters · filed 2021-05-13 | $1.53K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$456.15K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$820.50K derived: sum of 2 quarters · filed 2021-03-18 | -$1.36M derived: sum of 3 quarters · filed 2021-03-18 | -$1.98M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$364.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$901.30K derived: sum of 2 quarters · filed 2020-11-13 | -$1.52M 10-Q · filed 2020-11-13 | -$976.99K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | -$536.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$1.16M 10-Q · filed 2020-08-13 | -$612.65K derived: sum of 3 quarters · filed 2020-08-13 | -$540.30K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$620.21K 10-Q · filed 2020-05-13 | -$75.69K derived: sum of 2 quarters · filed 2020-05-13 | -$3.34K derived: sum of 3 quarters · filed 2020-05-13 | $152.60K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $544.52K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $616.87K derived: sum of 2 quarters · filed 2020-03-27 | $772.82K derived: sum of 3 quarters · filed 2020-03-27 | $788.83K 10-K · filed 2020-03-27 | -$3.97M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | $72.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $228.29K derived: sum of 2 quarters · filed 2019-11-07 | $244.31K 10-Q · filed 2019-11-07 | -$3.78M 10-Q · filed 2018-11-01 | $1.67M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $155.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $171.96K 10-Q · filed 2019-08-01 | -$2.65M 10-Q · filed 2018-08-01 | $1.59M derived: sum of 3 quarters · filed 2019-08-01 | $246.03K derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2018-03-31 | $16.01K 10-Q · filed 2019-05-14 | -$1.41M 10-Q · filed 2018-05-01 | $1.44M derived: sum of 2 quarters · filed 2019-05-14 | $90.08K derived: sum of 3 quarters · filed 2019-05-14 | $1.86M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $74.07K derived: sum of 2 quarters · filed 2019-02-21 | $1.84M derived: sum of 3 quarters · filed 2019-02-21 | $898.10K 10-K · filed 2019-02-21 | ||||
| 2017-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $419.27K derived: sum of 2 quarters · filed 2018-11-01 | -$524.14K 10-Q · filed 2018-11-01 | $1.30M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $824.03K 10-Q · filed 2018-08-01 | $2.64M derived: sum of 3 quarters · filed 2018-08-01 | $1.95M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | -$943.42K 10-Q · filed 2018-05-01 | $876.85K derived: sum of 2 quarters · filed 2018-05-01 | $187.32K derived: sum of 3 quarters · filed 2018-05-01 | -$365.72K derived: sum of 4 quarters · filed 2018-05-01 | ||||
| 2016-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.13M derived: sum of 2 quarters · filed 2018-03-01 | $577.69K derived: sum of 3 quarters · filed 2018-03-01 | $1.42M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | -$689.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$1.24M derived: sum of 2 quarters · filed 2017-11-01 | -$399.71K 10-Q · filed 2017-11-01 | -$345.04K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | -$553.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $289.82K 10-Q · filed 2017-08-01 | $344.48K derived: sum of 3 quarters · filed 2018-03-01 | $1.42M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $842.86K 10-Q · filed 2017-05-03 | $897.53K derived: sum of 2 quarters · filed 2018-03-01 | $1.97M derived: sum of 3 quarters · filed 2018-03-01 | $1.53M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $54.66K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.13M derived: sum of 2 quarters · filed 2018-03-01 | $688.92K derived: sum of 3 quarters · filed 2018-03-01 | -$71.75K 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $634.25K derived: sum of 2 quarters · filed 2016-11-01 | -$126.42K 10-Q · filed 2016-11-01 | -$304.02K derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | -$442.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$1.20M 10-Q · filed 2016-08-03 | -$1.38M derived: sum of 3 quarters · filed 2017-03-02 | |||||
| 2015-03-31 | -$760.67K 10-Q · filed 2016-05-03 | -$938.27K derived: sum of 2 quarters · filed 2017-03-02 | ||||||
| 2014-12-31 | -$177.60K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $526.87K 10-K · filed 2017-03-02 | ||||||
| 2014-09-30 | $704.47K 10-Q · filed 2015-11-06 | |||||||
| 2013-12-31 | -$1.66M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |